Cytotoxic quinolines (Part 2)1. Azolylalkylamino and-thio quinolines

Drug Design and Discovery

Volumn 14, Issue 1, 1996, Pages 31-42

  Abel, Mark D ^a   Ha, Chan M ^a   Luu, Hiep T ^a   Micetich, Ronald G ^a   Nguyen, Dai Q ^a   Nukatsuka, Mamoru ^b   Oreski, A Bernadette ^a   Tempest, Mark L ^a   Daneshtalab, Mohsen ^a  

^a NAEJA Pharmaceutical Inc   (Canada)

^b TAIHO PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Anticancer; Azolylalkylaminoquinolines; Azolylalkylthioquinolines; Cytotoxic

Indexed keywords

CYTOTOXIC AGENT; DOXORUBICIN; QUINOLINE DERIVATIVE;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; CYTOTOXICITY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; OXIDATION; STRUCTURE ACTIVITY RELATION;

AMINOQUINOLINES; ANIMALS; ANTINEOPLASTIC AGENTS; AZO COMPOUNDS; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; QUINOLINES; SULFHYDRYL COMPOUNDS; TUMOR CELLS, CULTURED;

EID: 0029875828     PISSN: 10559612     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (3)

1. Part 1 of this series appears elsewhere in this journal.
2. Gillies, R.J., Didier, N. and Denton, M. (1986) Determination of Cell Number in Monolayer Cultures. Anal. Biochem., 159, 109-113.
3. Alley, M.C., Scudiero, D.A., Monks, A., Hursey, M.L., Czerwinski, M.J., Fine, D.L., Abbot, B.J., Mayo, J.G., Shoemaker. R.H. and Boyd, M.R. (1988) Feasibility of Drug Screening with Panels of Human Tumor Cell Lines Using a Microculture Tetrazolium Assay. Cancer Res., 48, 589-601.